Erschienen:
Springer Science and Business Media LLC, 2021
Erschienen in:JA Clinical Reports
Sprache:
Englisch
DOI:
10.1186/s40981-021-00467-3
ISSN:
2363-9024
Entstehung:
Anmerkungen:
Beschreibung:
<jats:title>Abstract</jats:title><jats:sec>
<jats:title>Introduction</jats:title>
<jats:p>We report a case of COVID-19 with <jats:italic>Legionella</jats:italic> co-infection that was treated successfully.</jats:p>
</jats:sec><jats:sec>
<jats:title>Case report</jats:title>
<jats:p>A 73-year-old man presented to the hospital with symptoms of fatigue that continued for the next 5 days. The patient was receiving docetaxel and prednisolone chemotherapy for prostate cancer. Laboratory findings on admission showed positive urine <jats:italic>Legionella</jats:italic> antigen test and SARS-CoV-2 test. He was administered antiviral and antibacterial agents, and a corticosteroid. Pneumonia exacerbated on day 2 of hospitalization. The patient underwent tracheal intubation and began receiving multidisciplinary care. On day 8 of hospitalization, his oxygenation improved, and the patient was extubated. He discharged on day 27 of hospitalization.</jats:p>
</jats:sec><jats:sec>
<jats:title>Conclusions</jats:title>
<jats:p>The patient had a favorable outcome with early diagnosis and early treatment of both diseases. Patients with severe COVID-19 disease need to be evaluated for co-infection. Further, early diagnosis and early treatment of the microbial bacteria causing the co-infection are important.</jats:p>
</jats:sec>